Orthofix Medical Inc. Quarterly Selling and Marketing Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Orthofix Medical Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2010 to Q2 2024.
  • Orthofix Medical Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $100M, a 0.98% increase year-over-year.
  • Orthofix Medical Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $393M, a 27.7% increase year-over-year.
  • Orthofix Medical Inc. annual Selling and Marketing Expense for 2023 was $386M, a 68.6% increase from 2022.
  • Orthofix Medical Inc. annual Selling and Marketing Expense for 2022 was $229M, a 3.39% increase from 2021.
  • Orthofix Medical Inc. annual Selling and Marketing Expense for 2021 was $221M, a 8.26% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $393M $100M +$975K +0.98% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $392M $100M +$6.25M +6.67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $386M $97.7M +$38.4M +64.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $347M $94.9M +$39.5M +71.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $308M $99.2M +$39.4M +65.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $268M $93.8M +$39.7M +73.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $229M $59.3M +$2.23M +3.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $227M $55.5M -$636K -1.13% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $227M $59.9M +$2.55M +4.45% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $225M $54.1M +$3.35M +6.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $221M $57.1M +$3.38M +6.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $218M $56.1M +$3.17M +5.99% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $215M $57.3M +$13.9M +31.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $201M $50.8M -$3.53M -6.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $204M $53.7M -$4.6M -7.88% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $209M $52.9M -$1.88M -3.43% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $211M $43.5M -$13.4M -23.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $224M $54.3M +$619K +1.15% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $224M $58.3M +$4.48M +8.32% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $219M $54.8M +$4.91M +9.83% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $214M $56.9M +$5.34M +10.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $209M $53.7M +$3.43M +6.82% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $206M $53.8M +$1.96M +3.78% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $204M $49.9M +$2.41M +5.06% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $201M $51.5M +$1.06M +2.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $200M $50.3M +$1.74M +3.58% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $198M $51.9M +$3.17M +6.51% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $195M $47.5M +$5.78M +13.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 $189M $50.5M +$4.43M +9.62% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $185M $48.5M +$3.71M +8.28% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-30
Q4 2016 $181M $48.7M +$3.99M +8.91% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 $177M $41.7M -$4.41M -9.56% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-30
Q2 2016 $182M $46M +$3.1M +7.21% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $179M $44.8M +$537K +1.21% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $178M $44.7M +$2.36M +5.56% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $176M $46.1M +$5.13M +12.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 $171M $42.9M +$933K +2.22% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $170M $44.3M +$3.11M +7.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $167M $42.4M -$3.64M -7.92% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $170M $41M +$1.92M +4.92% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $168M $42M -$2.53M -5.67% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $171M $41.2M -$4.67M -10.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-18
Q4 2013 $175M $46M +$4.46M +10.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $171M $39.1M -$3.95M -9.17% Jul 1, 2013 Sep 30, 2013 10-Q 2015-03-31
Q2 2013 $175M $44.5M -$2.54M -5.39% Apr 1, 2013 Jun 30, 2013 10-Q 2015-03-31
Q1 2013 $177M $45.8M -$1.28M -2.72% Jan 1, 2013 Mar 31, 2013 10-Q/A 2015-03-31
Q4 2012 $179M $41.5M +$11.3M +37.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-04-29
Q3 2012 $167M $43M -$6.34M -12.8% Jul 1, 2012 Sep 30, 2012 10-Q 2014-03-25
Q2 2012 $174M $47.1M -$2.89M -5.78% Apr 1, 2012 Jun 30, 2012 10-Q 2014-03-24
Q1 2012 $177M $47.1M -$8.47M -15.2% Jan 1, 2012 Mar 31, 2012 10-Q/A 2014-03-24
Q4 2011 $185M $30.2M Oct 1, 2011 Dec 31, 2011 10-K/A 2015-03-31
Q3 2011 $49.4M -$7.92M -13.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $50M -$7.23M -12.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-30
Q1 2011 $55.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $57.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $57.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.